Literature DB >> 22359222

Increased FDG uptake in breast cancer is associated with prognostic factors.

Yasemin Sanli1, Serkan Kuyumcu, Zeynep Gozde Ozkan, Göknur Işik, Hasan Karanlik, Burcu Guzelbey, Cuneyt Turkmen, Sevda Ozel, Ekrem Yavuz, Ayse Mudun.   

Abstract

PURPOSE: To evaluate the relationship between FDG uptake and prognostic factors of breast cancer such as hormone receptors (estrogen and progesterone), expression of c-erbB-2, axillary lymph node status, tumor histology, grade and size.
MATERIALS AND METHODS: Between May 2009 and February 2011; 79 patients (mean age ± SD: 52.9 ± 13.9 years) with biopsy proven breast cancer underwent F-18 FDG PET/CT scanning for staging. Patients with excisional biopsy or neoadjuvant chemotherapy were excluded from the study. Histological types included were invasive ductal carcinoma (n = 68), invasive lobular carcinoma (n = 2), and invasive ductal plus lobular mixed carcinoma (n = 9). Maximum standardized uptake values (SUVmax) were compared with estrogen (ER) and progesterone receptors (PR), expression of c-erbB-2, as well as tumor grade and tumor size. For the evaluation of relationship between tumor SUVmax values and prognosticators such as hormone receptors, tumor histologic grade, and tumor size, statistical analyses were performed using Student t test, Mann-Whitney U Test and Pearson correlation coefficient and p values of less than 0.05 were considered to indicate statistically significant differences.
RESULTS: All primary breast neoplasms were detected by PET/CT scanner. The mean SUVmax values and breast cancer tumor sizes ranged from 2.09 to 39.0 and 0.7 to 10 cm, respectively. Tumors with negative ER [(n = 19); SUVmax median (min-max): 15 (2.09-39.0)] were associated with higher SUVmax values (p = 0.01). Tumors with overexpression of C-erbB-2 [(n = 28); SUVmax median (min-max): 16.0 (5.0-39.0)]; tumor grade 3 [(n = 25); SUVmax median (min-max): 15 (6.43-39)]; axillary lymph node involvement [(n = 60); SUVmax median (min-max): 13.61 (4.0-39.0)]; tumor histopathology and increased tumor size were associated with higher maximum standardized uptake values. However, PR did not show any relationship with SUVmax values.
CONCLUSION: In the present report, strong relationships were detected between the negativity of ER, overexpression of c-erbB-2, tumor grade, tumor size, histopathology, axillary lymph node involvement and SUVmax values. Accordingly, we believe that SUVmax values obtained with (18)F-FDG PET/CT may provide some information about tumor biology of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359222     DOI: 10.1007/s12149-012-0579-2

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  18 in total

1.  Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson.

Authors:  Kıvanç Birsoy; David M Sabatini; Richard Possemato
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  Relationship Between FDG Uptake and the Platelet/lymphocyte Ratio in Patients With Breast Invasive Ductal Cancer.

Authors:  Takaaki Fujii; Shoko Tokuda; Yuko Nakazawa; Sasagu Kurozumi; Sayaka Obayashi; Reina Yajima; Ken Shirabe
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  PET/CT and breast cancer subtypes.

Authors:  Laura Gilardi; Marco Colleoni; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09       Impact factor: 9.236

4.  Preoperative FDG PET/CT in breast cancer patients: where are we going?

Authors:  Laura Gilardi; Concetta De Cicco; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11       Impact factor: 9.236

5.  Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.

Authors:  Ana María García Vicente; Angel Soriano Castrejón; Miguel Angel Cruz Mora; Ana González Ageitos; María del Mar Muñoz Sánchez; Alberto León Martín; Ruth Espinosa Aunión; Fernanda Relea Calatayud; Vicente Muñoz Madero; Ignacio Chacón López-Muñiz; Jose Manuel Cordero García; Germán Andrés Jiménez Londoño
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-28       Impact factor: 9.236

6.  Prognostic Significance of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Operable Primary Breast Cancer.

Authors:  Jahae Kim; Su Woong Yoo; Sae-Ryung Kang; Sang-Geon Cho; Jong-Ryool Oh; Ari Chong; Jung-Joon Min; Hee-Seung Bom; Jung-Han Yoon; Ho-Chun Song
Journal:  Nucl Med Mol Imaging       Date:  2012-08-25

7.  Factors Associated with (18)F-Fluorodeoxyglucose Uptake in T1 and T2 Invasive Ductal Carcinoma of the Breast.

Authors:  So Jung Kim; Seong-Jang Kim; In Joo Kim; Kyoungjune Pak; Bum Soo Kim; Seunghyeon Shin
Journal:  Nucl Med Mol Imaging       Date:  2016-03-23

8.  Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.

Authors:  Na Young Jung; Sung Hun Kim; Bo Bae Choi; Sung Hoon Kim; Mi Sook Sung
Journal:  World J Surg Oncol       Date:  2015-03-15       Impact factor: 2.754

9.  [18F]-fluorodeoxyglucose positron emission tomography can contribute to discriminate patients with poor prognosis in hormone receptor-positive breast cancer.

Authors:  Sung Gwe Ahn; Minkyung Lee; Tae Joo Jeon; Kyunghwa Han; Hak Min Lee; Seung Ah Lee; Young Hoon Ryu; Eun Ju Son; Joon Jeong
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

Review 10.  Application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part I. Diagnosis of breast cancer prior to treatment.

Authors:  Elżbieta Jodłowska; Rafał Czepczyński; Anna Wyszomirska; Grażyna Jarząbek; Witold Kędzia; Marek Ruchała
Journal:  Contemp Oncol (Pozn)       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.